Advisory Services Network’s 10x Genomics TXG Stock Holding History

Advisory Services Network’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-78	Closed	-$912	–	4090
2025 Q3	$912	Buy	+78	New	+$1.02K	﹤0.01%	3945
2024 Q1	–	Sell	-24	Closed	-$1.34K	–	3506
2023 Q4	$1.34K	Buy	+24	New	+$1.04K	﹤0.01%	3483
2023 Q2	–	Sell	-24	Closed	-$1.34K	–	3510
2023 Q1	$1.34K	Hold	24	–	–	﹤0.01%	3549
2022 Q4	$875	Buy	+24	New	+$785	﹤0.01%	3621
2022 Q1	–	Sell	-2,357	Closed	-$351K	–	1547
2021 Q4	$351K	Buy	2,357 +208	+10%	+$31.9K	0.01%	1041
2021 Q3	$313K	Buy	2,149 +183	+9%	+$31.4K	0.01%	1081
2021 Q2	$385K	Buy	+1,966	New	+$356K	0.01%	985
2021 Q1	–	Sell	-211	Closed	-$30K	–	2828
2020 Q4	$30K	Buy	+211	New	+$30.6K	﹤0.01%	1939

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's TXG Position: Q4 2025 in Review

Advisory Services Network sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 78 shares — an estimated $912 sold.

Advisory Services Network first reported a position in TXG in Q4 2020 and held it in 8 quarters. The position peaked at $385K in Q2 2021. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

Advisory Services Network reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
Advisory Services Network sold 78 10x Genomics shares in Q4 2025, an estimated $912.
Advisory Services Network first reported a position in 10x Genomics in Q4 2020 and held it in 8 quarters.
Advisory Services Network's 10x Genomics position peaked at $385K in Q2 2021.
322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.